Louisiana Blue Healthcare Economist Mike Bertaut explores that question in this Straight Talk video.
Remember, Melanotan is a synthetic tanning agent that poses serious health risks
How do you interpret the observation that AF risk was reduced even in patients who gained weight while on a GLP-1 receptor agonist what might this suggest about the underlying mechanism
Kreiner FF, von Scholten BJ, Kurtzhals P, Gough SCL
You do not know what is in the medications you are purchasing
Gill A, Hoogwerf B, Burger J, Bruce S, MacConell L, Yan P, Braun D, Giaconia J, Malone J: Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study